|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Physiology, Australian Institute of Sport, Canberra, Australian Capital Territory, Australia
2 Institute for Exercise and Environmental Medicine, Presbyterian Hospital of Dallas, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States; Institut Nacional d'Educacio Fisica de Catalunya, Universitat de Barcelona, Av. de l'Estadi, s/n, Barcelona, 08038, Spain
3 Institute for Exercise and Environmental Medicine, Presbyterian Hospital of Dallas, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States; Faculty of Human Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, Texas, Netherlands
4 New South Wales Institute of Sport, Sydney, New South Wales, Australia
5 Institute for Exercise and Environmental Medicine, Dallas, Texas, United States; Park City, Utah, United States
6 Institute for Exercise and Environmental Medicine, Dallas, Texas, United States; Medicine, University of Texas at Southwestern/IEEM, Dallas, Texas, United States
* To whom correspondence should be addressed. E-mail: chris.gore{at}ausport.gov.au.
This study tested the hypothesis that athletes exposed to 4 wk of intermittent hypobaric hypoxia exposure (IHE 3h/d, 5d/wk at 4000-5500m) or double-blind placebo increase their red blood cell volume (RCV) and hemoglobin mass (Hbmass) secondary to an increase in erythropoietin (EPO). Twenty-three collegiate level athletes were measured before (PRE) and after (POST) the intervention for RCV via Evans blue (EB) dye, and in duplicate for Hbmass using CO-rebreathing. Hematological indices including EPO, soluble transferrin receptor (sTfr) and reticulocyte parameters were measured on 8-10 occasions spanning the intervention. The subjects were randomly divided among hypobaric hypoxia (HYPO n=11) and normoxic (NORM n=12) groups. Apart from doubling EPO concentration 3h after hypoxia there was no increase in any of the measures for either HYPO or NORM groups. The mean change in RCV from PRE to POST for the HYPO group was 2.3% (95% confidence limits = -4.8 to 9.5%) and for the NORM group was -0.2% (-5.7 to 5.3%). The corresponding changes in Hbmass were 1.0% (-1.3 to 3.3%) for HYPO and -0.3% (-2.6 to 3.1%) for NORM. There was good agreement between blood volume (BV) from EB and CO; BVEB = 1.03 BVCO + 142, r2=0.85, p<0.0001. Overall, evidence from four independent techniques (RCV, Hbmass, reticulocyte parameters and sTfr) suggests that IHE did not accelerate erythropoiesis despite the increase in serum EPO.
This article has been cited by other articles:
![]() |
T. V. Serebrovskaya, E. B. Manukhina, M. L. Smith, H. F. Downey, and R. T. Mallet Intermittent Hypoxia: Cause of or Therapy for Systemic Hypertension? Experimental Biology and Medicine, June 1, 2008; 233(6): 627 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Truijens, F. A. Rodriguez, N. E. Townsend, J. Stray-Gundersen, C. J. Gore, and B. D. Levine The effect of intermittent hypobaric hypoxic exposure and sea level training on submaximal economy in well-trained swimmers and runners J Appl Physiol, February 1, 2008; 104(2): 328 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Rodriguez, M. J. Truijens, N. E. Townsend, J. Stray-Gundersen, C. J. Gore, and B. D. Levine Performance of runners and swimmers after four weeks of intermittent hypobaric hypoxic exposure plus sea level training J Appl Physiol, November 1, 2007; 103(5): 1523 - 1535. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Fu, N. E. Townsend, S. M. Shiller, E. R. Martini, K. Okazaki, S. Shibata, M. J. Truijens, F. A. Rodriguez, C. J. Gore, J. Stray-Gundersen, et al. Intermittent hypobaric hypoxia exposure does not cause sustained alterations in autonomic control of blood pressure in young athletes Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1977 - R1984. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |